Development of Biomarkers of Transient Ischemic Attack

Abstract

Abstract:

Transient ischemic attack (TIA) is an early-warning alarm for stroke. As of yet, no known blood marker reliably predicts stroke risk after TIA. The present research focuses on TIA biomarkers to identify high risk patients rapidly and accurately. In this article, we provide a review on the development of TIA biomarkers involving stress hormones, inflammatory factors, thrombosis factors. Meanwhile, the paper gives a brief introduction about gene sequencing and metabonomics methods in the application of stroke risk prediction after TIA.

Key words: Transient ischemic attack; Stroke; Proediction; Biomarkers

摘要：

短暂性脑缺血发作（transient ischemic attack，TIA）是卒中的危险预警信号。至今尚无公认的对卒中风险预测价值高的TIA的生物学标志物。寻找快速而准确的TIA后卒中风险的生物学标志物是目前研究的热点。本文从应激激素、炎症因子、血栓形成因子等方面对TIA后卒中风险的生物学标志物研究进行综述，并简要介绍基因测序及代谢组学等方法在TIA后卒中风险预测中的应用。

关键词: 短暂性脑缺血发作; 卒中; 预测; 标志物

PEI Lu-Lu, FANG Hui, ZHAO Lu, XU Yu-Ming, SONG Bo.. Development of Biomarkers of Transient Ischemic Attack[J]. Chinese Journal of Stroke, 2015, 10(05): 442-446.

裴璐璐，方慧，赵璐，许予明，宋波. 短暂性脑缺血发作生物学标志物研究进展[J]. 中国卒中杂志, 2015, 10(05): 442-446.

References

1 Kokubo Y. Epidemiology of transient ischemic attack[J]. Front Neurol Neurosci, 2014, 33:69-81.

2 Giles MF, Rothwell PM. Risk of stroke early after transient ischaemic attack:a systematic review and meta-analysis[J]. Lancet Neurol, 2007, 6:1063-1072.

3 Johnston SC, Rothwell PM, Nguyen-Huynh MN, et al. Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack[J]. Lancet, 2007, 369:283-292.

4 Amarenco P, Labreuche J, Lavallee PC. Patients with transient ischemic attack with ABCD2<4 can have similar 90-day stroke risk as patients with transient ischemic attack with ABCD2>/=4[J]. Stroke, 2012, 43:863-865.

5 Perry JJ, Sharma M, Sivilotti ML, et al. Prospective validation of the ABCD2 score for patients in the emergency department with transient ischemic attack[J]. CMAJ, 2011, 183:1137-1145.

6 Merwick A, Albers GW, Amarenco P, et al. Addition of brain and carotid imaging to the ABCD2 score to identify patients at early risk of stroke after transient ischaemic attack:a multicentre observational study[J]. Lancet Neurol, 2010, 9:1060-1069.

7 Neidert S, Katan M, Schuetz P, et al. Anterior pituitary axis hormones and outcome in acute ischaemic stroke[J]. J Intern Med, 2011, 269:420-432.

8 Katan M, Fluri F, Morgenthaler NG, et al. Copeptin:a novel, independent prognostic marker in patients with ischemic stroke[J]. Ann Neurol, 2009, 66:799-808.

9 Katan M, Nigro N, Fluri F, et al. Stress hormones predict cerebrovascular re-events after transient ischemic attacks[J]. Neurology, 2011, 76:563-566.

10 De Marchis GM, Weck A, Audebert H, et al. Copeptin for the prediction of recurrent cerebrovascular events after transient ischemic attack:results from the CoRisk study[J]. Stroke, 2014, 45:2918-2923.

11 Tobin MK, Bonds JA, Minshall RD, et al. Neurogenesis and inflammation after ischemic stroke:what is known and where we go from here[J]. J Cereb Blood Flow Metab, 2014, 34:1573-1584.

12 Emerging Risk Factors Collaboration, Kaptoge S, Di Angelantonio E, et al. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality:an individual participant meta-analysis[J]. Lancet, 2010, 375:132-140.

13 Purroy F, Montaner J, Molina CA, et al. C-reactive protein predicts further ischemic events in transient ischemic attack patients[J]. Acta Neurol Scand, 2007, 115:60-66.

14 Corso G, Bottacchi E, Brusa A, et al. Blood C-reactive protein concentration with ABCD(2) is a better prognostic tool than ABCD(2) alone[J]. Cerebrovasc Dis, 2011, 32:97-105.

15 Cucchiara B L, Messe SR, Sansing L, et al. Lipoprotein-associated phospholipase A2 and C-reactive protein for risk-stratification of patients with TIA[J]. Stroke, 2009, 40:2332-2336.

16 Cai A, Zheng D, Qiu R, et al. Lipoprotein-associated phospholipase A2 (Lp-PLA[2]):a novel and promising biomarker for cardiovascular risks assessment[J]. Dis Markers, 2013, 34:323-331.

17 Vittos O, Toana B, Vittos A, et al. Lipoprotein-associated phospholipase A2 (Lp-PLA2):a review of its role and significance as a cardiovascular biomarker[J]. Biomarkers, 2012, 17:289-302.

18 Massot A, Pelegri D, Penalba A, et al. Lipoprotein-associated phospholipase A2 testing usefulness among patients with symptomatic intracranial atherosclerotic disease[J]. Atherosclerosis, 2011, 218:181-187.

19 Delgado P, Chacon P, Penalba A, et al. Lipoprotein-associated phospholipase A(2) activity is associated with large-artery atherosclerotic etiology and recurrent stroke in TIA patients[J]. Cerebrovasc Dis, 2012, 33:150-158.

20 Whiteley W, Jackson C, Lewis S, et al. Inflammatory markers and poor outcome after stroke:a prospective cohort study and systematic review of interleukin-6[J]. PLoS Med, 2009, 6:e1000145.

21 Simundic AM, Basic V, Topic E, et al. Soluble adhesion molecules in acute ischemic stroke[J]. Clin Invest Med, 2004, 27:86-92.

22 Selvarajah JR, Smith CJ, Hulme S, et al. Does inflammation predispose to recurrent vascular events after recent transient ischaemic attack and minor stroke? The North West of England transient ischaemic attack and minor stroke (NORTHSTAR) study[J]. Int J Stroke, 2011, 6:187-194.

23 Whiteley W, Wardlaw J, Dennis M, et al. The use of blood biomarkers to predict poor outcome after acute transient ischemic attack or ischemic stroke[J]. Stroke, 2012, 43:86-91.

24 Mustonen P, Lehtonen KV, Javela K, et al. Persistent antiphospholipid antibody (aPL) in asymptomatic carriers as a risk factor for future thrombotic events:a nationwide prospective study[J]. Lupus, 2014, 23:1468-1476.

25 Mullen MT, Messe SR, Kasner SE, et al. Anti-phosphatidylserine-prothrombin antibodies are associated with outcome in a TIA cohort[J]. Front Neurol, 2012, 3:137.

26 De Meyer SF, Stoll G, Wagner DD, et al. von Willebrand factor:an emerging target in stroke therapy[J]. Stroke, 2012, 43:599-606.

27 Di Castelnuovo A, Agnoli C, De Curtis A, et al. Elevated levels of D-dimers increase the risk of ischaemic and haemorrhagic stroke. Findings from the EPICOR Study[J]. Thromb Haemost, 2014, 112:941-946.

28 Segal HC, Burgess AI, Poole DL, et al. Population-based study of blood biomarkers in prediction of subacute recurrent stroke[J]. Stroke, 2014, 45:2912-2917.

29 Greisenegger S, Segal HC, Burgess AI, et al. Biomarkers and mortality after transient ischemic attack and minor ischemic stroke:population-based study[J]. Stroke, 2015, 46:659-666.

30 Mauri-Capdevila G, Jove M, Suarez-Luis I, et al. Metabolomics in ischaemic stroke, new diagnostic and prognostic biomarkers[J]. Rev Neurol, 2013, 57:29-36.

31 Jiang Z, Sun J, Liang Q, et al. A metabonomic approach applied to predict patients with cerebral infarction[J]. Talanta, 2011, 84:298-304.

32 Zhan X, Jickling G C, Tian Y, et al. Transient ischemic attacks characterized by RNA profiles in blood[J]. Neurology, 2011, 77:1718-1724.

33 Jove M, Mauri-Capdevila G, Suarez I, et al. Metabolomics predicts stroke recurrence after transient ischemic attack[J]. Neurology, 2015, 84:36-45.

[1]	CAO Liming, REN Lijie. Progress and Prospects of Diagnosis and Treatment Techniques for Acute Ischemic Stroke [J]. Chinese Journal of Stroke, 2024, 19(9): 983-989.
[2]	FU Pengcheng, CAO Liming, ZHU Jiaqian, ZHAO Guiyu, XU Gelin. Research Progress of Reperfusion Therapy for Large Artery Atherosclerotic Ischemic Stroke [J]. Chinese Journal of Stroke, 2024, 19(9): 1004-1011.
[3]	ZHANG Liping, CAO Liming, XIAO Nan, LIAO Yuqi, CHI Feng, YU Yanni, REN Lijie. Research Progress and Challenges of Nanomaterials in the Diagnosis and Treatment of Ischemic Stroke [J]. Chinese Journal of Stroke, 2024, 19(9): 1012-1017.
[4]	JIANG He, WANG Cheng, CHEN Xianghua, XU Chunxiang. Predictive Value of Five Prehospital Stroke Screening Scales for In-Hospital Acute Large Vessel Occlusive Ischemic Stroke [J]. Chinese Journal of Stroke, 2024, 19(9): 1018-1024.
[5]	WANG Xiaorui, LUO Song, ZOU Liangyu, QU Hongdang, CUI Xue, ZHAO Yujie. Value of Eosinophil-to-Monocyte Ratio in Predicting the Prognosis of Patients with Acute Ischemic Stroke Receiving Intravenous Thrombolysis [J]. Chinese Journal of Stroke, 2024, 19(9): 1025-1033.
[6]	ZHONG Ya’nan, YOU Xuemei, DI Haili, MENG Lin, SUN Lingling. The Value of Serum Cathepsin L Level Combined with ABCD³-I Score in Predicting the Short-Term of Cerebral Infarction of TIA Patients [J]. Chinese Journal of Stroke, 2024, 19(9): 1034-1039.
[7]	WANG Shuo, YU Ping, ZHANG Ning, WANG Chunxue. Bibliometric Analysis of References on the Correlation between Ischemic Stroke and Sleep from 2013 to 2023 [J]. Chinese Journal of Stroke, 2024, 19(9): 1040-1047.
[8]	ZHOU Hongyu, LI Zixiao, WANG Yongjun. Research Progress on Radiomics-Based Brain Age Prediction and Ischemic Stroke [J]. Chinese Journal of Stroke, 2024, 19(9): 1066-1076.
[9]	ABULANIYAZI Anaguli, WU Xiaoxin, LI Jiaoxing, LI Zhuhao, SHENG Wenli. Research Progress on Factors Related to the Susceptibility Vessel Sign and its Clinical Application in Acute Ischemic Stroke [J]. Chinese Journal of Stroke, 2024, 19(9): 1077-1085.
[10]	YANG Jinbo, ZHANG Cong. Progress on the Application of High-Resolution Vessel Wall Imaging in Patients with Ischemic Stroke [J]. Chinese Journal of Stroke, 2024, 19(9): 1086-1093.
[11]	WU Chunyan, YIN Yashi, WANG Guangzhi, YUE Kuitao. Evaluation and Application of Medical Imaging for Acute Ischemic Stroke at Different Time Windows: A Review [J]. Chinese Journal of Stroke, 2024, 19(9): 1094-1101.
[12]	WANG Ye, WEI Chenming, LI Xiuli, WU Jian. Application of Diversified Teaching Model in Stroke Green Channel Training at a Medical University-Affiliated Teaching Hospital [J]. Chinese Journal of Stroke, 2024, 19(9): 1102-1109.
[13]	SHAN Kai, ZHAO Meng, WANG Chunjuan, LI Zixiao, WANG Xiaoyan. Exploration and Practice of Diagnosis and Treatment Models for Stroke and Comorbid Conditions [J]. Chinese Journal of Stroke, 2024, 19(8): 863-865.
[14]	ZHANG Mengruo, XU Shouchen, SUI Cuicui, LI Yukui, WANG Xueli. The Effects of Lower Limb Rehabilitation Robot Combined with Scalp Acupuncture on the Walking Efficiency and Coordination Function in Elderly Patients with Ischemic Stroke [J]. Chinese Journal of Stroke, 2024, 19(8): 902-908.
[15]	XUE Mingyue, ZHANG Huixin, SU Dan, LI Lixia, LI Jingwei, LI Hong. Analysis of the Influencing Factors of Medication Adherence in Ischemic Stroke Patients [J]. Chinese Journal of Stroke, 2024, 19(8): 909-914.